Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205 - www.ClinicalTrials.gov
A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-Small-Cell Lung Cancer (NSCLC) - www.ClinicalTrials.gov
Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib - www.ClinicalTrials.gov
Phase 2 Study of Maintenance OSI-906 Plus Erlotinib (Tarceva), or Placebo Plus Erlotinib in Patients With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy
Side Effects may Increase, tell your Doctor if you experience any of the following:
Loss of Appetite
Bone or Muscle Pain
Numbness, Burning, or Tingling of the Hands or Feet
Swelling of the Arms, Hands, Feet, Ankles, or Lower Legs
Darkening of Skin
Change in Appearance of Hair and Nails
Serious Side Effects
Shortness of Breath
Fever or Chills
Chest Pain or Pressure
Pain in the Arms, Neck, or Upper Back
Rapid, Irregular, or Pounding Heartbeat
Slow or Difficult Speech
Dizziness or Faintness
Weakness or Numbness of an Arm or Leg
Unusual Bruising or Bleeding
Black and Tarry or Bloody Stools
Bloody Vomit or that looks like Coffee Grounds
Pale or Yellow Skin
Redness, Warmth, Pain, Tenderness, or Swelling in One Leg
Skin Issues -
Rash (may look like acne and may affect the skin on the face, upper chest, or back
Eye Issues -
Growth of Eyelashes on the inside of the eyelid
Van, JJ Gompel, et al. "Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Emerging Therapies for the Treatment of
Patients With Vestibular Schwannomas." Neurosurgery (2017).
| DOI: 10.1093/neuros/nyx516
Plotkin, Scott R., et al. "Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients."
Otology & neurotology: official publication of the American Otological Society, American Neurotology Society [and] European
Academy of Otology and Neurotology 31.7 (2010): 1135.
| DOI: 10.1097/MAO.0b013e3181eb328a
Plotkin, Scott R., et al. "Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy."
Nature Reviews Clinical Oncology 5.8 (2008): 487.
| DOI: 10.1038/ncponc1157